F-box/LRR-repeat protein 7 is genetically associated with Alzheimer's disease

Annals of Clinical and Translational Neurology

Volumn 2, Issue 8, 2015, Pages 810-820

  Tosto, Giuseppe ^a,b   Fu, Hongjun ^a   Vardarajan, Badri N ^a,b   Lee, Joseph H ^a,b   Cheng, Rong ^a,b   Reyes Dumeyer, Dolly ^a,b   Lantigua, Rafael ^c   Medrano, Martin ^d   Jimenez Velazquez, Ivonne Z ^e   Elkind, Mitchell S V ^b,f   Wright, Clinton B ^g   Sacco, Ralph L ^g   Pericak Vance, Margaret ^g   Farrer, Lindsay ^h   Rogaeva, Ekaterina ⁱ   St George Hyslop, Peter ^i,j   Reitz, Christiane ^a,b,f   Mayeux, Richard ^a,b,f  

^a Department of Medicine   (United States)

^b Vagelos College of Physicians and Surgeons   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

^d Pontificia Universidad Catolica Madre y Maestra   (Dominican Republic)

^e UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^f University of Toronto ^*  (United States)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

F BOX PROTEIN; LEUCINE RICH REPEAT KINASE 7; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FBXL7 GENE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HISPANIC; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING;

EID: 84996777256     PISSN: None     EISSN: 23289503     Source Type: Journal    
DOI: 10.1002/acn3.223     Document Type: Article

References (44)

1. Thies W, Bleiler L. 2013 Alzheimer's disease facts and figures. Alzheimers Dement 2013;9:208-245.
2. Slooter AJ, Cruts M, Kalmijn S, et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 1998;55:964-968.
3. Lambert J-C, Heath S, Even G, et al. Genome-wide association study indentifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009;41:1094-1099.
4. Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009;41:1088-1093.
5. Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74, 046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013;45:1452-1458.
6. Tosto G, Reitz C. Genome-wide association studies in Alzheimer's disease: a review. Curr Neurol Neurosci Rep 2013;13:1-7.
7. Tang M-X, Cross P, Andrews H, et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 2001;56:49-56.
8. Reitz C, Jun G, Naj A, et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ε(lunate)4, and the risk of late-onset Alzheimer disease in African Americans. JAMA 2013;309:1483-1492.
9. Vardarajan BN, Schaid DJ, Reitz C, et al. Inbreeding among Caribbean Hispanics from the Dominican Republic and its effects on risk of Alzheimer disease. Genet Med 2014;doi:10.1038/gim.2014.161.
10. Vardarajan BN, Faber KM, Bird TD, et al. Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA). JAMA Neurol 2014;71:315-323.
11. Tang M-X, Stern Y, Marder K, et al. The APOE-e(open)4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 1998;279:751-755.
12. Lee JH, Cheng R, Barral S, et al. Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol 2011;68:320-328.
13. Sacco RL, Anand K, Lee H-S, et al. Homocysteine and the risk of ischemic stroke in a triethnic cohort the Northern Manhattan Study. Stroke 2004;35:2263-2269.
14. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263-269.
15. Marchini J, Howie B, Myers S, et al. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007;39:906-913.
16. Consortium 1000 Genomes Project, others. An integrated map of genetic variation from 1, 092 human genomes. Nature 2012;491:56-65.
17. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006;38:209-213.
18. Price AL, Patterson NJ, Plenge RM, et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909.
19. Patterson N, Price AL, Reich D. Population structure and eigenanalysis. PLoS Genet 2006;2:e190.
20. Shriner D. Investigating population stratification and admixture using eigenanalysis of dense genotypes. Heredity 2011;107:413-420.
21. Zhu X, Li S, Cooper RS, Elston RC. A unified association analysis approach for family and unrelated samples correcting for stratification. Am J Hum Genet 2008;82:352-365.
22. Manichaikul A, Mychaleckyj JC, Rich SS, et al. Robust relationship inference in genome-wide association studies. Bioinformatics 2010;26:2867-2873.
23. Li M-X, Gui H-S, Kwan JS, Sham PC. GATES: a rapid and powerful gene-based association test using extended Simes procedure. Am J Hum Genet 2011;88:283-293.
24. Alexander DH, Novembre J, Lange K. Fast model-based estimation of ancestry in unrelated individuals. Genome Res 2009;19:1655-1664.
25. Naj AC, Jun G, Beecham GW, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 2011;43:436-441.
26. Ong RT-H, Teo Y-Y. varLD: a program for quantifying variation in linkage disequilibrium patterns between populations. Bioinformatics 2010;26:1269-1270.
27. Mucke L, Masliah E, Yu G-Q, et al. High-level neuronal expression of Abeta1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 2000;20:4050-4058.
28. Santacruz K, Lewis J, Spires T, et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005;309:476-481.
29. Mayford M, Bach ME, Huang Y-Y, et al. Control of memory formation through regulated expression of a CaMKII transgene. Science 1996;274:1678-1683.
30. Myers AJ, Gibbs JR, Webster JA, et al. A survey of genetic human cortical gene expression. Nat Genet 2007;39:1494-1499.
31. Liang WS, Reiman EM, Valla J, et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci USA 2008;105:4441-4446.
32. Lambert J-C, Grenier-Boley B, Harold D, et al. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry 2012;18:461-470.
33. Rodrigues-Campos M, Thompson BJ. The ubiquitin ligase FbxL7 regulates the Dachsous-Fat-Dachs system in Drosophila. Development 2014;141:4098-4103.
34. Liu Y, Lear T, Zhao Y, et al. F-box protein Fbxl18 mediates polyubiquitylation and proteasomal degradation of the pro-apoptotic SCF subunit Fbxl7. Cell Death Dis 2015;6:e1630.
35. Bosch JA, Sumabat TM, Hafezi Y, et al. The Drosophila F-box protein Fbxl7 binds to the protocadherin Fat and regulates Dachs localization and Hippo signaling. Elife 2014;3:e03383.
36. Kim M-Y, Mo J-S, Ann E-J, et al. Regulation of Notch1 signaling by the APP intracellular domain facilitates degradation of the Notch1 intracellular domain and RBP-Jk. J Cell Sci 2011;124:1831-1843.
37. Watanabe T, von der Kammer H, Wang X, et al. Neuronal expression of F-box and leucine-rich-repeat protein 2 decreases over Braak stages in the brains of Alzheimer's disease patients. Neurodegener Dis 2012;11:1-12.
38. Di Fonzo A, Dekker M, Montagna P, et al. FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome. Neurology 2009;72:240-245.
39. Shu R, Wong W, Ma Q, et al. APP intracellular domain acts as a transcriptional regulator of miR-663 suppressing neuronal differentiation. Cell Death Dis 2015;6:e1651.
40. Zhang Y, Kent JW, Olivier M, et al. A comprehensive analysis of adiponectin QTLs using SNP association, SNP cis-effects on peripheral blood gene expression and gene expression correlation identified novel metabolic syndrome (MetS) genes with potential role in carcinogenesis and systemic inflammation. BMC Med Genomics 2013;6:14.
41. Shi H, Medway C, Bullock J, et al. Analysis of Genome-Wide Association Study (GWAS) data looking for replicating signals in Alzheimer's disease (AD). Int J Mol Epidemiol Genet 2010;1:53.
42. Bryan KJ, Lee H, Perry G, et al. Transgenic mouse models of Alzheimer's disease: behavioral testing and considerations. 2009.
43. Rosenberg NA, Huang L, Jewett EM, et al. Genome-wide association studies in diverse populations. Nat Rev Genet 2010;11:356-366.
44. Lin P-I, Vance JM, Pericak-Vance MA, Martin ER. No gene is an island: the flip-flop phenomenon. Am J Hum Genet 2007;80:531-538.